Summary
Boston Scientific announced plans to acquire Nalu Medical, a company that develops technology for chronic pain relief. The acquisition, valued at $500 million, is expected to finalize in the first half of 2026. Boston Scientific anticipates increased sales and significant growth following the acquisition.
Key Facts
- Boston Scientific plans to buy Nalu Medical for $500 million.
- The acquisition is expected to be completed by the first half of 2026.
- Nalu Medical specializes in technology for chronic pain relief.
- The Nalu Neurostimulation System is used to manage chronic pain with a minimally invasive method.
- Boston Scientific has invested in Nalu Medical since 2017.
- Nalu Medical secured $65 million in Series E funding in 2023.
- Boston Scientific expects to see $60 million in sales from Nalu in 2025 with 25% growth in 2026.
- Boston Scientific has made multiple acquisitions in recent years and reported high revenue in 2024.
